BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 11280075)

  • 1. Interleukin-13 in Iranian patients with visceral leishmaniasis: relationship to other Th2 and Th1 cytokines.
    Babaloo Z; Kaye PM; Eslami MB
    Trans R Soc Trop Med Hyg; 2001; 95(1):85-8. PubMed ID: 11280075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody and cytokine levels in visceral leishmaniasis patients with varied parasitemia before, during, and after treatment in patients admitted to Arba Minch General Hospital, southern Ethiopia.
    Tadesse D; Abdissa A; Mekonnen M; Belay T; Hailu A
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009632. PubMed ID: 34351903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
    Hailu A; van der Poll T; Berhe N; Kager PA
    Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of circulating levels of interferon-gamma, interleukin-10 and tumor necrosis factor-alpha in patients with visceral leishmaniasis.
    de Medeiros IM; Castelo A; Salomão R
    Rev Inst Med Trop Sao Paulo; 1998; 40(1):31-4. PubMed ID: 9713135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IFN-γ, IL-2, IP-10, and MIG as Biomarkers of Exposure to
    Ibarra-Meneses AV; Ghosh P; Hossain F; Chowdhury R; Mondal D; Alvar J; Moreno J; Carrillo E
    Front Cell Infect Microbiol; 2017; 7():200. PubMed ID: 28620584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elongation factor-2, a Th1 stimulatory protein of Leishmania donovani, generates strong IFN-γ and IL-12 response in cured Leishmania-infected patients/hamsters and protects hamsters against Leishmania challenge.
    Kushawaha PK; Gupta R; Sundar S; Sahasrabuddhe AA; Dube A
    J Immunol; 2011 Dec; 187(12):6417-27. PubMed ID: 22079980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
    Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
    J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum profile of IL-1β and IL-17 cytokines in patients with visceral leishmaniasis.
    Babaloo Z; Oskoei MR; Kohansal MH; Barac A; Ahmadpour E
    Comp Immunol Microbiol Infect Dis; 2020 Apr; 69():101431. PubMed ID: 32059125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Balance of IL-10 and interferon-gamma plasma levels in human visceral leishmaniasis: implications in the pathogenesis.
    Caldas A; Favali C; Aquino D; Vinhas V; van Weyenbergh J; Brodskyn C; Costa J; Barral-Netto M; Barral A
    BMC Infect Dis; 2005 Dec; 5():113. PubMed ID: 16364177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous IL-4 is necessary for effective drug therapy against visceral leishmaniasis.
    Alexander J; Carter KC; Al-Fasi N; Satoskar A; Brombacher F
    Eur J Immunol; 2000 Oct; 30(10):2935-43. PubMed ID: 11069076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.
    Kemp K; Kemp M; Kharazmi A; Ismail A; Kurtzhals JA; Hviid L; Theander TG
    Clin Exp Immunol; 1999 Jun; 116(3):500-4. PubMed ID: 10361241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis.
    Sundar S; Reed SG; Sharma S; Mehrotra A; Murray HW
    Am J Trop Med Hyg; 1997 May; 56(5):522-5. PubMed ID: 9180602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses of Iranian patients with visceral leishmaniasis and recovered individuals to LCR1 of Leishmania infantum.
    Niknam HM; Abrishami F; Doroudian M; Rostamian M; Moradi M; Khaze V; Iravani D
    Clin Vaccine Immunol; 2014 Apr; 21(4):518-25. PubMed ID: 24501341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential production of Th1- and Th2-derived cytokines does not determine the genetically controlled or vaccine-induced rate of cure in murine visceral leishmaniasis.
    Kaye PM; Curry AJ; Blackwell JM
    J Immunol; 1991 Apr; 146(8):2763-70. PubMed ID: 1901883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania infantum-specific production of IFN-γ and IL-10 in stimulated blood from dogs with clinical leishmaniosis.
    Solano-Gallego L; Montserrrat-Sangrà S; Ordeix L; Martínez-Orellana P
    Parasit Vectors; 2016 Jun; 9(1):317. PubMed ID: 27260142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endogenous interleukin-18 is involved in immunity to Leishmania donovani but its absence does not adversely influence the therapeutic activity of sodium stibogluconate.
    Mullen AB; Lawrence CE; McFarlane E; Wei XQ; Carter KC
    Immunology; 2006 Nov; 119(3):348-54. PubMed ID: 16879623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania donovani phosphoproteins pp41 and pp29 re-establishes host protective immune response in visceral leishmaniasis.
    Das P; Amit A; Singh SK; Chaudhary R; Dikhit MR; Yadav A; Pandey K; Das VN; Sundram S; Das P; Bimal S
    Parasitol Int; 2015 Feb; 64(1):18-25. PubMed ID: 25224164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichotomy of protective cellular immune responses to human visceral leishmaniasis.
    Khalil EA; Ayed NB; Musa AM; Ibrahim ME; Mukhtar MM; Zijlstra EE; Elhassan IM; Smith PG; Kieny PM; Ghalib HW; Zicker F; Modabber F; Elhassan AM
    Clin Exp Immunol; 2005 May; 140(2):349-53. PubMed ID: 15807861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.